(Q35307059)

7 August 2017

title

In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria (English)

1 reference

7 August 2017

main subject

gram-positive bacteria

0 references

author name string

A W Chow

series ordinal

1

1 reference

7 August 2017

N Cheng

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 May 1988

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

32

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

788-790

1 reference

Deficient autolytic enzyme activity in antibiotic-tolerant lactobacilli

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

In vitro susceptibility of gram-positive cocci to paldimycin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

Effect of calcium on in vitro activity of LY146032 against Clostridium difficile

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

In vitro activity of LY146032 against staphylococci, streptococci, and enterococci

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172278

27 July 2018

Identifiers

DOI

10.1128/AAC.32.5.788

1 reference

7 August 2017

1 reference

7 August 2017

1 reference